[Development of Multimodal Intervention in Cancer Cachexia].

Area of Science:

• Oncology
• Metabolic Medicine
• Clinical Nutrition

Background:

• Cancer cachexia is characterized by metabolic abnormalities and symptoms impacting eating and activity, leading to significant weight loss.
• Currently, a universally safe and effective multimodal treatment for cancer cachexia remains unestablished.
• Patient quality of life is severely affected by the progressive nature of cancer cachexia.

Purpose of the Study:

• To review the current landscape of cancer cachexia management.
• To explore the potential of combining pharmacological and non-pharmacological approaches.
• To highlight the importance of a multidisciplinary team and patient education in addressing cancer cachexia.

Main Methods:

• Review of existing literature on cancer cachexia treatments.
• Discussion of emerging pharmacological agents, such as anamorelin hydrochloride.
• Emphasis on the integration of nutrition, physical therapy, medical, nursing, and psychological support.

Main Results:

• Clinical studies are investigating the combination of anamorelin hydrochloride with other therapies.
• A multidisciplinary team approach is crucial for comprehensive patient care.
• Education for healthcare professionals, patients, and families is vital for effective management.

Conclusions:

• A multimodal strategy, integrating new pharmacological options with supportive care, is essential for managing cancer cachexia.
• The establishment of specialized multidisciplinary teams is recommended for optimal patient outcomes.
• Enhanced education and awareness are key components in the fight against cancer cachexia.